Tag: products

AstraZeneca Awarded $60M Contract To Manufacture Antibody Products

Posted on by Eric Coffie

AstraZeneca, Gaithersburg, Maryland, was awarded a $60,000,000 firm-fixed-price contract to manufacture AZD7442, a combination antibody product intended to prevent or treat clinical effects of SARS-CoV-2, for a minimum of 100,000 treatment courses. Work will be performed in Gaithersburg, Maryland, with an estimated completion date of June 30, 2021. Fiscal 2020 Army general funds in the amount of $30,000,000 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity (W911QY-20-C-0119). (Awarded Sept. 30, 2020)

AstraZeneca Pharmaceuticals (AstraZeneca US), a subsidiary of UK-based global drugmaker AstraZeneca, is a significant player in the US pharmaceuticals market. The company’s sales represent about a third of its parent’s revenues. AstraZeneca US’ treatments focus on several therapeutic areas: cardiovascular, renal, metabolic, oncology, and respiratory disorders. Its best-known products include asthma medicine Symbicort; cancer drugs Tagrisso, Faslodex, and Imfinzi; and cardiovascular treatments Brilinta and Farxiga (cardiovascular). The company operates several R&D and manufacturing locations across the US.(dnb.com)

 

RFP For A Multiple Award IDIQ Contract for NAWCAD WOLF – Engineering Products and Technical Services

Posted on by Eric Coffie

This is a Request for Proposal (RFP). The Government’s intent is to award a Multiple Award (MA) Indefinite Delivery Indefinite Quantity (IDIQ) contract to each and all qualifying Offerors whose proposal is technically evaluated as “acceptable”, with an estimated award of 07 June 2021. The contract will have a five (5) year ordering period. The resulting contract will have Cost Reimbursable and Cost Plus Fixed Fee and Firm Fixed Price CLINS; therefore, successful awardee will be required to have an adequate accounting system upon contract award.

The Government will not accept or respond to telephone calls or requests for meetings with potential Offerors about this requirement. All questions regarding this procurement must be submitted via email to Brandon Reaser at brandon.reaser@navy.mil. It is requested that all questions be received within 10 calendar days of the date this solicitation is issued. Questions received after 10 calendar days may not be answered prior to the proposal due date.

  • Product Service Code: D399 – IT AND TELECOM- OTHER IT AND TELECOMMUNICATIONS
  • NAICS Code: 541330 – Engineering Services
  • Place of Performance: Webster Field Saint Inigoes , MD 20684 USA
  • Updated Response Date: Nov 17, 2020 02:00 pm EST

Full details via beta.sam.gov

govcon giants logo Check out our RESOURCES page for a sample letter that we use in response to government market research.

Pfizer Inc. New York Awarded $48,683,161 Contract For Pharmaceutical Products

Posted on by Eric Coffie

Pfizer Inc., New York, New York, has been awarded a maximum $48,683,161 fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity contract for pharmaceutical products. This was a competitive acquisition with 18 offers received. This is a one-year base contract with nine one-year option periods. Location of performance is New York, with an Aug. 31, 2021, ordering period end date. Using customers are Army, Navy, Air Force, Marine Corps and federal civilian agencies.

Type of appropriation is fiscal 2020 through 2021 Warstopper funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania.

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide. (bloomberg.com)